Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

PARTICIPATING COMPANIES

Companies participating at Biotech Showcase 2019 to date.

 
USA

10x Genomics

 
 
United States

11.2 Capital

 
 
United States

1812 Ventures

 
USA

2Morrow Inc

 
USA

315 Ventures Ltd.

 
 
Australia

360biolabs

 
 
United States

3E Bioventures

 
 
Singapore

3V SourceOne Capital

 
 
United Kingdom

4BIO Capital

 
 
United States

5AM Ventures

 
USA

60 Degrees Pharma

 
 
United States

7wire Ventures

 
 
USA

89bio Inc.

 
 
Israel

89bio Ltd

 
Singapore

A STAR

 
Singapore

A Star Research Entities

 
USA

A6 Pharmaceuticals

 
 
USA

Aadi Bioscience Inc

 
 
USA

Aagami, Inc.

 
 
USA

Ab Studio Inc

 
Czech Republic

AbCheck s.r.o.

 
 
USA

AbCheck, Inc.

 
 
United States

Aberdeen Investment Management

 
 
United States

ABES Venture Partners

 
 
United Kingdom

Abingworth LLP

 
 
USA

Absorption Systems

 
USA

Academy of Managed Care Pharmacy

 
Canada

Acasti Pharma

 
 
Canada

Accelera Canada

 
 
United States

Accelerator Life Science Partners

 
Canada

Accel-Rx Health Sciences Accelerato

 
USA

Access Vascular

 
 
USA

Accolade Pharma

 
 
United States

Aceras Life Sciences

 
 
United States

Aceras Partners

 
USA

Achelios Therapeutics

 
USA

Achelois Oncology

 
 
United States

Acorn Campus Taiwan

 
 
USA

Actinium Pharmaceuticals Inc

 
USA

Actym Therapeutics, Inc.

 
USA

Acucela, Inc.

 
USA

AcuraStem

 
 
United States

Acuris Partners

 
Japan

AcuuRna Inc.

 
Australia

AdAlta Ltd

 
Spain

Adan Medical Innovation

 
USA

Adaptive Biotechnologies Corp

 
 
USA

Adaptive Phage Therapeutics

 
USA

Adare Pharmaceuticals

 
 
Spain

ADASTRA Ventures S.L.

 
 
USA

AdCure Bio, LLC

 
USA

Adjuvant Partners

 
Spain

ADVANCED MARKER DISCOVERY SL

 
 
United States

Advanced Regenerative Manufacturing Institute (ARMI)

 
USA

Advicenne Pharma

 
 
United States

Aegis Capital Corp.

 
 
USA

Aegle Therapeutics Corp

 
 
Germany

Aescuvest

 
 
USA

Aevi Genomic Medicine

 
 
USA

Affigen

 
USA

AGC Biologics

 
 
United States

Agent Capital

 
 
USA

AgeX Therapeutics, Inc.

 
 
USA

Agile Therapeutics

 
 
Netherlands

Aglaia Biomedical Ventures

 
 
Netherlands

Aglaia Oncology Funds

 
 
United States

Agnovos Healthcare

 
Finland

Aiforia Inc / Fimmic Oy

 
 
USA

AIM Targeted Therapies

 
USA

Aisling Capital LLC

 
 
USA

AIVITA Biomedical

 
Japan

Ajinomoto Co., Inc.

 
 
USA

Aktivax Inc

 
 
USA

Alacrita Consulting Inc

 
 
United Kingdom

Alacrita Holdings Limited

 
 
United Kingdom

Albion Capital

 
USA

Albumedix

 
 
USA

Alcami Corp

 
 
USA

Alcami Corporation

 
 
United States

Alignment Ventures, LLC

 
 
USA

Allevi

 
 
USA

Alliant Insurance Services

 
 
Canada

AllosteRx Capital

 
United Kingdom

Almac Discovery

 
 
United States

Alpha square group

 
 
Israel

Alpha Tau Medical Ltd.

 
 
United States

Alpine BioVentures, GP LLC

 
South Korea

Alteogen Inc

 
 
United States

American Angels Inc

 
 
USA

American Business Television Networ

 
 
USA

American Gene Technologies

 
 
Israel

aMoon

 
 
Israel

aMoon Fund

 
 
Canada

AmorChem

 
 
Canada

AmorChem II Ventures Inc.

 
 
USA

Amorsa Therapeutics, Inc.

 
Netherlands

Amphera BV

 
USA

Ampliphi Biosciences Inc

 
 
Canada

Amplitude Ventures

 
Sweden

AMRA Medical Inc.

 
 
USA

AMRI

 
 
Japan

Anaeropharma Science

 
 
France

Andera Partners

 
 
United States

Angel Investor

 
 
United States

angelMD Advisors, LLC

 
Japan

AnGes Inc.

 
 
United Kingdom

Angle Plc

 
 
United States

Anglo Scientific

 
 
USA

Anima Biotech Inc

 
 
USA

Ansun Biopharma, Inc.

 
 
Denmark

Antag Therapeutics ApS

 
Canada

Antibe Therapeutics Inc

 
 
USA

Antidote Therapeutics

 
 
Italy

Anya Capital

 
Austria

AOP Orphan Pharmaceuticals AG

 
Spain

Aortyx

 
 
United States

Apex Capital

 
 
United Kingdom

Apex Healthcare Consulting Ltd

 
 
Germany

Apollo Ventures

 
France

APTEEUS

 
 
USA

Aptose Biosciences

 
USA

Aqua Partners LLC

 
USA

Aquestive Therapeutics

 
 
USA

Arch Therapeutics

 
 
United States

Arcus Ventures

 
 
USA

ARENSIA Exploratory Medicine

 
 
USA

Aridis Pharmaceuticals

 
 
United States

Aristar Capital

 
USA

Aristea Therapeutics, Inc.

 
 
USA

Arivale Inc.

 
 
United Kingdom

Arix Bioscience Plc

 
 
United States

ARIZONA TECHNOLOGY INVESTORS

 
USA

Array Ventures

 
USA

ARTham Therapeutics

 
Spain

Arthex

 
 
United Kingdom

Arthurian Life Sciences

 
 
United States

Artiman Ventures

 
 
United States

Asahi Kasei

 
 
United States

Asahi Kasei America, Inc.

 
 
Japan

Asajes Ventures

 
 
United States

Ascend Capital Partners

 
 
United States

Ascendiant Capital

 
USA

Asdera

 
USA

Ash Ingredients

 
 
France

ASKLEPIOS ADVISORS

 
Canada

Aspect Biosystems

 
 
United States

Aspire Capital Partners

 
USA

Astellas Innovation Management

 
Japan

Astellas Pharma Inc.

 
 
United States

Astellas Venture Management

 
Japan

Astelllas Pharma Inc.

 
USA

AstraZeneca

 
USA

Astrocyte Pharmaceuticals

 
 
USA

Ataia Medical

 
United Kingdom

Atelix Ltd

 
 
United States

Athena Bioventures

 
 
United States

Atheneos Ventures, LLC

 
 
United States

Atlas Venture

 
USA

Atreca Inc

 
 
Germany

Atriva Therapeutics GmbH

 
USA

Attenua, inc

 
 
USA

ATUM

 
 
USA

aTyr Pharma Inc

 
USA

August Therapeutics, Inc.

 
 
USA

Auransa Inc

 
 
Japan

Aurora Partners K.K.

 
Australia

AusBiotech Ltd

 
United Kingdom

Autolus Limited

 
United Kingdom

Avacta Life Sciences

 
USA

Avalia Immunotherapies

 
USA

Avaliv Therapeutics, Inc.,

 
 
Ireland

Avectas

 
Ireland

Avectas Ltd

 
 
USA

Avid Bioservices Inc

 
USA

Avisa Pharma

 
South Korea

Avixgen Inc.

 
USA

AVM Biotechnology

 
USA

AvroBio

 
USA

Axolo Pharma

 
 
USA

Axsome Therapeutics, Inc.

 
USA

Aytu BioScience Inc

 
 
USA

AyuVis Research

 
 
USA

Azitra

 
 
USA

AzurRx BioPharma

 
 
United States

B. Riley FBR, Inc.

 
 
USA

Bachem Americas Inc

 
 
USA

Back Bay Life Science Advisors

 
 
United States

Baidu Ventures

 
 
United States

Baird Capital

 
 
USA

Baker McKenzie

 
 
United States

Band of Angels

 
 
Germany

Bannert-Manik Consultants

 
USA

Bantam Pharmaceutical

 
USA

Bantam Pharmaceutical, LLC

 
USA

Barbara Ryan Advisors

 
USA

BARDA

 
 
United States

BARDA / HHS

 
USA

Bastion Biologics

 
 
United States

Bay City Capital

 
USA

Bay Labs

 
Germany

Bayer Healthcare Pharma AG

 
USA

Bayer LifeHub Boston

 
USA

Bayer USA LLC

 
USA

Baylor Scott & White Research Institute

 
 
USA

BBA

 
 
Canada

BDC Healthcare Fund

 
 
China

Beijing Delian Investment & Management Co., Ltd.

 
 
China

Beijing Delian Investment & Management Co.,Ltd.

 
 
China

BEIJING SUNFOREST CAPITAL CO., LTD

 
 
USA

Bell Biosystems, Inc.

 
 
United States

Belle Meade Ventures LLC

 
Greece

Benostan

 
 
Norway

BerGenBio ASA

 
 
Japan

Beyond Next Ventures

 
 
Japan

Beyond Next Ventures Inc.

 
 
Netherlands

BGV

 
USA

BIO

 
 
Australia

Bio Capital Impact Fund

 
 
India

Bio Ideations LLP

 
USA

bioAffinity Technologies, Inc.

 
USA

Bioasis

 
 
USA

Bioasis Technologies

 
 
Australia

BioCapital Impact Fund

 
USA

BioCentury

 
USA

Biocom

 
USA

Biodesy Inc

 
USA

BioFactura Inc

 
 
Netherlands

BioGeneration Ventures

 
 
Germany

BioGenes GmbH

 
 
United States

BioHealth Innovation, Inc.

 
 
United States

BioInnovation Capital

 
 
Australia

Biointelect

 
 
South Korea

Biois Co Ltd

 
Canada

Biolab Pharma

 
 
Israel

BioLineRx

 
USA

Biolojic Design Inc.

 
 
Israel

Biolojic Design Ltd

 
 
USA

BioMarker Strategies, LLC

 
New Zealand

Biomatters Limited

 
 
United States

Biomedical Advanced Research and Development Authority

 
 
United States

Biomedical Advanced Research and Development Authority (BARDA)

 
 
United States

Biomedical Advanced Research and Development Authority (BARDA) within ASPR/HHS

 
 
United States

Biomedical Advanced Research and Development Authority (BARDA), U.S. Department of Health and Human Services

 
 
Switzerland

BioMedPartners AG

 
 
United States

BioMotiv LLC

 
 
France

Bionest Partners Finance

 
 
South Korea

Bionetix Inc

 
 
Australia

Bionomics Ltd

 
Germany

Biontech AG

 
 
Spain

Bionure Farma, S.L.

 
 
USA

BioPharma Global

 
France

Biophytis

 
 
Denmark

BioPorto A/S

 
 
Canada

BioPubKSS.com

 
 
Belgium

BIoqube Ventures

 
 
USA

BioQuest

 
 
United States

Bios Equity Partners, LP

 
 
United States

Bios Partners

 
 
Australia

BioScience Managers Pty Ltd

 
 
United States

BioSense Global

 
China

Biosion Inc.

 
 
Israel

Biosphere Capital

 
USA

BioSymetrics

 
Canada

BIOTECanada

 
 
Australia

Biotech Capital Impact Fund

 
 
United States

Biotech Investment Group

 
 
Switzerland

Biotechgate

 
 
United States

Biotechnology Investments

 
USA

Biotechnology Investors

 
China

Bio-Thera Solutions

 
USA

BioTrak Therapeutics

 
Switzerland

BioVersys AG

 
 
USA

BioWorld

 
 
USA

Bioxcel Therapeutics

 
Brazil

BioZeus

 
Germany

BLAC-BioPharma UG

 
USA

Bloomberg

 
USA

BlueJay Mobile Health, Inc

 
 
USA

BlueWillow Biologics, Inc.

 
USA

Body Vision Medical

 
 
China

BOHE Angel Fund

 
 
Germany

BOLTENDAHL INTERNATIONAL PARTNERS

 
 
Netherlands

BOM Brabant Ventures

 
USA

Boston Biotech Conferences

 
 
USA

Boston Neurosciences

 
 
France

Bpifrance

 
 
France

Bpifrance Investissement

 
USA

BPTC

 
 
United States

Brace Pharma Capital

 
USA

Brainstorm Cell Therapeutics

 
Japan

Braizon Therapeutics, Inc.

 
 
Australia

Brandon Capital Partners

 
Poland

BRASTER S. A.

 
 
United Kingdom

Bridge Biotec Ltd

 
 
United Kingdom

Bridge Valley Ventures

 
USA

BridgeBio

 
USA

Bridgene Biosciences

 
USA

Bristol-Myers Squibb

 
 
United States

Broadview Ventures

 
 
United States

Broadview Ventures, Inc.

 
 
United States

Brock Capital

 
 
United States

Brookline Capital Markets

 
 
France

BROTHERS & PARTNERS EUROPE

 
USA

BURL Concepts, Inc.

 
USA

Buto Corporation

 
 
United States

Button Capital

 
 
USA

C14 Consulting Group LLC

 
 
USA

C3 Research Associates

 
 
Switzerland

CAH Capial GmbH

 
 
Switzerland

CAH Capital

 
 
USA

Cain Brothers

 
 
Spain

Caixa Capital Risc

 
United Kingdom

Calcivis Ltd

 
USA

Calidi Biotherapeutics

 
USA

California Life Sciences Association

 
USA

California Life Sciences Institute

 
USA

Calithera Biosciences

 
Taiwan

Caliway Biopharmaceutical Co. Ltd

 
USA

Camargo Pharmaceutical Services

 
Belgium

Camel-IDS NV

 
USA

Canale Communications

 
 
USA

Canalis Pharmaceuticals

 
 
USA

Cancer Advances

 
Israel

Can-Fite BioPharma

 
 
United States

Capgenic Advisors

 
 
Canada

Caprion Biosciences Inc

 
 
USA

Care Prepare

 
 
Germany

CARELA HOLDING

 
 
USA

Carmell Therapeutics

 
 
USA

CASI Pharmaceuticals

 
USA

CASI Pharmaceuticals Inc

 
 
USA

Catalent

 
 
Taiwan

Cathay Venture Inc.

 
 
China

C-Bridge Capital

 
 
USA

CBT Advisors

 
 
Canada

Ceapro, Inc.

 
USA

Celgene

 
 
Slovenia

Celica BIOMEDICAL

 
USA

Cell Care Therapeutics

 
 
USA

Cell Press

 
Canada

CellAegis Devices Inc.

 
 
USA

Cellectar Biosciences Inc

 
 
USA

CellFE

 
USA

Cellgen Diagnostics

 
 
USA

Cellmax Life

 
Australia

Cellmid

 
 
USA

Cello Health Consulting

 
 
Hong Kong

Cenova Capital

 
Mexico

Centro de Investigacion Sophia SA de CV

 
Switzerland

Cerbios-Pharma SA

 
 
USA

Cerebrum Corporation

 
 
USA

Certara

 
 
USA

CFO'Brien Consulting, LLC

 
 
USA

CG Life

 
 
United States

Chardan

 
 
United States

Charter Life Sciences

 
 
USA

Chemical & Engineering News

 
 
USA

ChemioCare Inc

 
Switzerland

ChinaBio Group

 
Canada

ChipCare

 
 
USA

Chronus Health

 
Spain

CIBER-BBN

 
 
United States

CincyTech

 
 
USA

Cingulate Therapeutics

 
 
United States

Cipla Limited

 
 
United States

Cipla New Ventures - unit of Cipla Limited

 
United Kingdom

Circassia Limited

 
United Kingdom

Circassia Pharmaceuticals

 
USA

Circle Pharma Inc

 
 
United Kingdom

Citigate Dewe Rogerson

 
 
USA

Citius Pharmaceuticals, Inc.

 
 
Canada

CiToxLab North America

 
USA

Clarify Health Solutions

 
 
USA

Clarivate Analytics

 
 
United States

Class Bravo Ventures

 
USA

ClearView Healthcare Partners

 
 
United States

Cleveland Clinic Ventures

 
 
Australia

Clinical Network Services

 
 
USA

Clinical Network Services Pty. Ltd.

 
 
Finland

Clinical Reserach Services Turku-CRST

 
USA

Cloud Pharmaceuticals, Inc.

 
USA

CLSA

 
 
United Kingdom

Clubb Capital Ltd

 
 
Switzerland

CMAB Biopharma

 
 
Australia

CMAX Clinical Research

 
 
Japan

CMIC HOLDINGS Co Ltd

 
 
USA

Cognate Bioservices

 
 
USA

Cognition Therapeutics

 
USA

Cognizance Biomarkers

 
USA

Colorado State University

 
USA

Compass Therapeutics

 
USA

Conatus Pharmaceuticals

 
 
USA

Concarlo Holdings LLC

 
 
USA

Connect Biopharmaceuticals

 
 
United States

Connecticut Innovations

 
 
United States

Connecticut Innovations, Inc.

 
USA

ConsortiaTX, Inc.

 
USA

ConSynance Therapeutics, Inc.

 
 
USA

Content Carnivores, LLC

 
 
USA

Context Therapeutics

 
 
USA

ContraFect Corporation

 
USA

Conway Communications

 
USA

Cook Regentec

 
Denmark

Copenhagen Capacity

 
South Korea

Corestem

 
USA

Coretelligent

 
 
USA

Cortexyme

 
 
Australia

CoSec Consulting

 
 
Switzerland

Coulter Partners

 
 
USA

Covance Inc

 
United Kingdom

Covington

 
Belgium

Covington & Burling

 
 
USA

Covington & Burling LLP

 
 
United States

Cowin Capital

 
 
China

Cowin Venture

 
 
USA

CPC Scientific

 
Canada

CQDM

 
USA

Creatv MicroTech, Inc.

 
 
United Kingdom

Crescendo Biologics Ltd

 
 
USA

Crosswave Management

 
 
USA

Cryoport

 
South Korea

CrystalGenomics, Inc.

 
USA

CTI

 
 
Canada

CTI Life Sciences Fund

 
 
Canada

CTI Life Sciences Fund II

 
USA

Cullgen, Inc.

 
 
United States

Cultivation Capital

 
 
New Zealand

Cure Kids Ventures

 
Germany

CureVac AG

 
 
USA

CV Sciences

 
 
United States

Cybernaut Zfounder Venture

 
 
USA

Cyclacel Pharmaceuticals, Inc.

 
Canada

Cyclenium Pharma

 
 
USA

CytoSen Therapeutics

 
 
USA

CytoSorbents Corporation

 
Denmark

Cytovac

 
South Korea

Daewoong Bio

 
South Korea

Daewoong Pharmaceutical Co LTD

 
South Korea

Daewoong Pharmaceutical Company

 
South Korea

Daewoong Pharmaceuticals

 
USA

Dana-Farber Cancer Institute

 
USA

Dana-Farber Cancer Institute & Harvard Medical School

 
 
Brazil

DANNEMANN SIEMSEN ADVOGADOS

 
 
USA

Davos Chemical Corporation

 
 
United States

Dawson James

 
 
Netherlands

DCprime bv

 
 
United Kingdom

DeBere Capital Partners

 
 
United States

Debere Capital Partners LLC

 
 
Switzerland

Debiopharm Innovation Fund SA

 
 
United States

Decheng Capital

 
 
United States

Decheng Captial

 
USA

Deerfield Management

 
 
USA

Defined Health

 
 
United States

DEFTA Partners

 
USA

DEL BioPharma

 
 
China

Delian Capital

 
 
Hong Kong

Delos Capital

 
Canada

Delphi Diagnostics

 
USA

Dementia Discovery Fund

 
USA

DesignMedix

 
 
United Kingdom

Destiny Pharma Plc

 
USA

DFA Consulting

 
 
United States

DFB Pharmaceuticals

 
 
United States

DFB Pharmaceuticals LLC

 
 
United States

DHVC

 
 
United States

Diamond Edge Ventures, Inc.

 
USA

Diffusion Pharmaceuticals Inc.

 
 
United States

Digital Expanse Ventures

 
 
United States

DigitalDx Ventures

 
USA

DigiTx Partners

 
 
United States

DigiTx Partners

 
Australia

Dimerix Ltd

 
USA

DiscoveryBioMed

 
 
USA

Diversigen

 
Switzerland

DKSH International Ltd

 
USA

DNALite Therapeutics

 
 
Sweden

DNB Bank ASA

 
 
United States

Dolby Family Ventures

 
South Korea

Dong-A ST

 
 
United States

Dorset Capital LLC and Par Equity USA

 
USA

Drexel

 
USA

Drexel University

 
 
Belgium

Droia NV

 
USA

DrugCendR Inc.

 
 
USA

DSI

 
USA

Dthera Sciences

 
 
USA

DTx Pharma

 
USA

Dualogics

 
 
USA

DUCK FLATS LLC

 
Spain

Duralock

 
 
USA

Dyadic International Inc

 
Japan

Dydo Group Holdings

 
 
United States

Dynamk Capital

 
Japan

EA Pharma Co., Ltd.

 
 
USA

EarlyDiagnostics, Inc

 
 
United States

Easton Capital Investment Group

 
USA

EBD

 
Germany

EBD Group

 
USA

EBD Group Inc

 
 
Switzerland

Eclosion2 SA

 
 
United States

EDBI

 
 
Singapore

EDBI Pte Ltd

 
United Kingdom

Edinburgh Molecular Imaging Ltd

 
USA

Edison

 
Japan

EditForce Inc

 
USA

Eefyian

 
 
China

Efung Capital

 
 
Puerto Rico

EGB Ventures

 
 
China

Eight Roads Venture

 
 
China

Eight Roads Ventures

 
 
Japan

Eight Roads Ventures Japan

 
United Kingdom

Elasmogen Ltd

 
 
USA

Elev8 New Media

 
USA

Elex Biotech

 
 
United States

Elm Street Ventures

 
 
USA

Eloxx Pharmaceuticals

 
China

Elpiscience Biopharma Ltd

 
 
United States

Emalfarb Investment Corporation

 
 
USA

Embera NeuroTherapeutics, Inc.

 
USA

Embleema

 
USA

EMD Serono

 
 
USA

Emerald Health Pharmaceuticals

 
Canada

Endoceutics

 
 
USA

Engine Room

 
 
USA

Enochian Biosciences

 
 
USA

Enteris BioPharma

 
Japan

Entrepreneur

 
USA

Envisagenics

 
 
France

ENYO Pharma

 
 
USA

EOC Pharma

 
Australia

EpiAxis Therapeutics

 
Belgium

EPICS Therapeutics

 
 
United Kingdom

Epidarex Capital Management LLP

 
Canada

EpigeneTherapeutics Inc.

 
USA

Epitracker

 
 
USA

EpiVax Oncology Inc

 
 
Japan

e-Projection

 
USA

Epygenix Therapeutics, Inc.

 
 
United Kingdom

ERA Consulting

 
USA

Erytech Pharma

 
 
Singapore

Esco Ventures Pte Ltd

 
 
Singapore

Esco Ventures X

 
 
United Kingdom

Esperante

 
 
United Kingdom

e-Therapeutics PLC

 
 
Belgium

eTheRNA Immunotherapies

 
South Korea

EuBiologics Co., Ltd.

 
 
Canada

Eurofins Alphora

 
South Korea

Eutilex

 
 
South Korea

Eutilex Co.,Ltd.

 
 
USA

Evaluate

 
USA

Evecxia Therapeutics

 
 
United Kingdom

Evolution Biotechnologies

 
 
United States

Evolution Life Science Partners

 
USA

Evotec

 
United Kingdom

Evox Therapeutics Limited

 
France

Ewin Consulting

 
 
United States

Excel Venture Management

 
USA

Excellentia Global Partners

 
 
USA

Exicure

 
United Kingdom

Exonate

 
Switzerland

F. Hoffmann-La Roche Ltd

 
USA

Fannin Innovation Studio

 
 
China

FaponCapital Inc.

 
 
Hungary

FastVentures

 
 
China

FC Capital

 
 
USA

FenoLogica Biosciences

 
Switzerland

Ferring Pharmaceuticals

 
USA

Ferring Research Institute Inc

 
Germany

Ferro Pharma GmbH

 
 
Germany

FGK Clinical Research GmbH

 
 
Netherlands

Fibriant BV

 
Japan

FIMECS, Inc.

 
 
Brazil

Fin Health Private Equity & Venture Capital

 
 
United States

Finney Capital

 
 
USA

FLAG Therapeutics

 
USA

Flatley Discovery Lab

 
 
Luxembourg

Flen Health SA

 
 
USA

Flow Pharma, Inc.

 
 
United States

FMG Ventures

 
USA

Foley Hoag

 
 
Germany

Forbion

 
 
United Kingdom

Fort Rock Capital

 
USA

Fortress Biotech

 
 
United States

Fortunatus Capital

 
 
United States

Fortune Venture Capital Co. Ltd

 
 
United States

Fosun Group

 
 
Switzerland

Fosun Pharmaceutical AG

 
USA

Foundation BioVentures

 
 
Ireland

Fountain Healthcare Partners

 
 
United States

FoxHill Asset Management

 
Germany

Fraunhofer IZI

 
USA

Freenome

 
 
USA

Fujifilm Diosynth Biotechnologies

 
 
Belgium

Fund+

 
USA

Fundamental Solutions corporation

 
Japan

FuturedMe Inc.

 
 
South Korea

G+FLAS Life Sciences, inc.

 
USA

G2L Touch, Inc

 
 
United States

G4S Capital

 
 
United States

GattoVC

 
 
Austria

GBA Pharma

 
South Korea

GC Pharma

 
 
United States

GCF Family Office

 
United Kingdom

GE Healthcare Life Sciences

 
USA

GE Healthcare Lifesciences

 
 
USA

Gel4Med

 
USA

Gemseki

 
 
USA

Genecopoeia

 
 
USA

Geneius Biotechnology, Inc.

 
 
Canada

Genesys Capital

 
 
USA

GeneTether, Inc

 
Switzerland

GeNeuro SA

 
 
USA

Genevant Sciences Inc

 
 
South Korea

Genexine

 
USA

Genisphere Llc

 
 
South Korea

Genome & Company

 
China

Genor BioPharma Co Ltd

 
 
USA

Genosco

 
 
USA

Genova Group

 
 
USA

Genprex, Inc.

 
USA

GeoVax Labs, Inc.

 
 
China

GF Venture Capital

 
USA

Gila Therapeutics

 
 
Netherlands

Gilde healthcare

 
 
Netherlands

Gilde Healthcare Partners

 
 
Netherlands

Gilde Healthcare Partners BV

 
 
Belgium

Gimv

 
 
Belgium

Gimv NV

 
USA

GlaxoSmithKline

 
Switzerland

Glenmark Pharmaceuticals SA

 
 
United States

Glickman Family Office

 
 
United States

Global Alpha Ventures

 
 
Canada

Global Connectworks Ltd

 
 
United States

Global Neurohealth Ventures

 
 
United States

Global Source Ventures, LLC

 
 
USA

GlobalData

 
 
USA

GlobalData Healthcare

 
USA

GlobalReach BI

 
USA

Glutalor Medical Inc.

 
USA

GlycoMimetics, Inc.

 
Taiwan

GlycoNex Inc.

 
Netherlands

Glycostem Therapeutics

 
Canada

Glysantis Inc.

 
 
United States

GMS Capital Partners LLC, A GMS Holdings Company

 
Germany

GNA Biosolutions GmbH

 
 
South Korea

GNT Pharma Co., Ltd.

 
 
South Korea

Gntpharma

 
USA

GO Therapeutics Inc

 
 
Taiwan

Golden Biotechnology Corp

 
 
United States

Golden Seeds LLC

 
 
United States

Good Health Capital New York

 
 
United States

GPB Capital

 
 
Czech Republic

Gradus/RSJ Life Sciences

 
USA

Gray Strategic Advisors, LLC

 
 
United States

GrayBella Capital

 
 
United States

Great Point Partners

 
 
USA

Greater Richmond Partnership

 
 
United States

Green Park & Golf Ventures

 
USA

Greenberg Traurig

 
 
Italy

Greenbone Ortho SRL

 
 
Australia

GreenLight Clinical

 
 
United States

Grey Sky Venture Partners

 
 
United States

Grey Sky Venture Partners, LLC

 
USA

GRIFOLS

 
 
United States

GSR Ventures

 
 
USA

GT Biopharma, Inc.

 
 
United States

H.C. Wainwright & Co.

 
USA

H.I.G. Capital

 
 
United States

H.I.G. Capital

 
USA

H1

 
 
Norway

Hadean Ventures

 
China

Haisco Pharmaceutical Ltd

 
France

HALIODX

 
 
United States

Haller Global Trust

 
South Korea

Hanmi Pharmaceutical

 
 
United States

Hatteras Venture Partners

 
 
USA

Hawaii Biotech

 
India

Healcraft Pharmaceuticals Pvt Ltd

 
Japan

HEALIOS K.K.

 
 
Japan

Healios KK

 
USA

Healogics

 
 
India

Health Passion Fund

 
USA

Health Scholars

 
Ireland

HealthBeacon

 
 
United States

Healthcare Angels

 
 
United States

Healthcare Capital Partners

 
 
United States

HealthCare Royalty Partners

 
 
United States

HealthTech capital

 
 
Singapore

Healthxcapital

 
 
USA

Heat Biologics

 
USA

Heather Shane Consulting

 
 
United States

HEDA Ventures

 
 
United States

Helicase Venture

 
 
United States

Helix Ventures

 
 
United States

Hemi Ventures

 
Germany

Heraeus Holding GmbH

 
United Kingdom

Heraeus Medical

 
 
United States

Hercules Capital

 
 
Singapore

Heritas Capital Management Pte Ltd

 
 
China

Hermed Equity Investment Management (Shanghai) Co., Ltd.

 
 
United States

Hermes life science ventures

 
 
Monaco

Hestia Investments Ltd.

 
USA

Hibernaid, Inc.

 
 
United States

High Country Venture

 
 
United States

High Networth Accrediated Individual Investor Who Actively Invests in Biotech, Life Sciences & Medical Technology Companies

 
 
Germany

HIgh-Tech Gruenderfonds Management GmbH

 
 
Germany

High-Tech Gründerfonds

 
 
USA

HighTide Therapeutics

 
 
United States

Hillman

 
USA

Hillstream BioPharma Inc.

 
China

HitGen Ltd.

 
USA

Hogan Lovells

 
 
China

Hongjing Capital

 
 
United States

Horizon Technology Finance Corporation

 
 
Hong Kong

Horizons Ventures

 
USA

Housey Pharma

 
Japan

HOYA

 
USA

Human Longevity Inc

 
Luxembourg

HuMiX

 
USA

Hunan Fangsheng Pharmaceutical

 
 
Turkey

Hurriyet

 
USA

HVH Precision Analytics L.L.c

 
Austria

I-APCELL

 
 
United States

Iaso Ventures

 
 
Israel

IBI Investment House Ltd

 
 
USA

ICR

 
 
USA

IDBiologics

 
USA

IDbyDNA, Inc.

 
 
South Korea

Ie Sung International

 
 
United Kingdom

IGEM Therapeutics Ltd

 
 
USA

IGF Oncology, LLC

 
 
United Kingdom

Illingworth Research Group Ltd

 
 
United States

IllinoisVENTURES

 
 
United States

Illumina Ventures

 
 
USA

illumiSonics, Inc.

 
Japan

iLung (Kyoto University)

 
 
USA

ImaginAb

 
 
Belgium

Imec.Xpand Comm. VA

 
Germany

ImevaX GmbH

 
USA

Immetas Therapeutics

 
USA

Immix Biopharma

 
USA

Immune Pharmaceuticals Inc

 
South Korea

ImmuneMed, Inc.

 
 
Germany

Immunic AG

 
Sweden

Immunicum

 
 
Sweden

Immunicum AB

 
 
USA

ImmunoMet Therapeutics

 
USA

ImmunoMolecular Therapeutics LLC

 
USA

Immunophotonics Inc

 
 
Israel

Immunovative Therapies,Ltd.

 
United Kingdom

ImmuPharma Plc

 
 
Australia

Imugene Limited

 
USA

INanoBio Inc

 
 
USA

InCarda Therapeutics

 
 
United States

InCube Ventures

 
 
USA

Incysus Therapeutics, Inc.

 
 
Italy

INDACO VENTURE PARTNERS SGR

 
 
USA

Indi Molecular

 
 
Sweden

Industrifonden

 
USA

Inflammatory Response Research, Inc.

 
USA

Informa - Pharma Intelligence

 
 
United Kingdom

InHealth Ventures

 
 
Netherlands

Inkef Capital BV

 
 
Canada

InMed Pharmaceuticals Inc.

 
 
United States

Inning One Ventures

 
 
Italy

Innogest Capital

 
Switzerland

Inositec AG

 
France

Inotrem

 
 
United States

Inovation Ventures

 
 
USA

Inovio Pharmaceuticals

 
France

Inserm Transfert

 
USA

Insilico Medicine, Inc.

 
France

Institut de Recherches International Servier

 
France

Institut de Recherches Servier

 
 
USA

Instrument Business Outlook

 
 
Canada

InSynchrony Ventures

 
Canada

Intellipharmaceutics Corp

 
USA

Intensity Therapeutics, Inc.

 
USA

Interpace Diagnostics

 
 
Belgium

Intrexon Actobiotcs

 
USA

Intrexon Corporation

 
 
United States

Intrinsic Value Investments LLC

 
Canada

Intrinsik Environmental Sciences Inc

 
USA

InveniAI Corporation

 
 
Spain

Inveready Asset Management

 
Lithuania

Invest Lithuania

 
 
Canada

Investing News Network

 
 
United States

Investmentor-tech coast angels

 
 
USA

Invivoscribe Technologies

 
Switzerland

iOnctura SA

 
 
United States

Ionic Ventures, LLC

 
United Kingdom

Iontas Limited

 
 
USA

Iota Biosciences, Inc.

 
 
United States

IP Group

 
 
United States

IP Group Inc

 
 
Switzerland

IPF Partners

 
 
Spain

Iproteos S.L.

 
 
United States

IPV Capital

 
France

IRIS

 
USA

IRISYS LLC

 
 
USA

IRTH Communications

 
 
USA

Ischemix, Inc.

 
 
Puerto Rico

Isla Pharmaceuticals

 
South Korea

ISU Abxis Co Ltd

 
 
Japan

Itochu Corporation

 
USA

iVeena Delivery Systems INC

 
Russian Fed.

IVIX Ltd

 
 
Canada

IWEUS CAPITAL

 
France

Ixaltis

 
 
Japan

JAFCO Co., Ltd.

 
 
USA

Jaguar Health, Inc.

 
USA

Janssen Pharmaceutical Co Johnson & Johnson

 
USA

Janssen R&D US

 
USA

JAZZ Venture Partners

 
 
United States

JD Capital

 
USA

JDRF

 
 
United States

JDRF T1D Fund

 
USA

Jenene Thomas Communications, LLC

 
 
United States

JGB Management Inc

 
 
United States

Jina Ventures Inc.

 
USA

Jivana Biotechnology Inc

 
USA

Johns Hopkins Technology Ventures

 
USA

Johnson & Johnson

 
USA

Johnson & Johnson Innovation

 
 
United States

Joseph Ventures I LLC

 
USA

Journey Medical Corporation

 
 
United States

Joyance Partners

 
Japan

JT Pharma

 
 
United States

Julz Co

 
 
United States

Julz Co LLC

 
USA

Jupiter Orphan Therapeutics

 
 
USA

KAER Biotherapeutics

 
Finland

Kaiku Health

 
USA

Kaiser Permanente Ventures

 
 
China

Kaitai Capital

 
USA

KaloCyte, Inc.

 
 
USA

Kalorama Information

 
Israel

Kamada

 
Sweden

Kancera

 
USA

Kaneka Americas Holding, Inc.

 
Japan

Kaneka Corporation

 
USA

Kantar Health

 
 
Sweden

Karolinska Development AB

 
 
Australia

Kazia Therapeutics Limited

 
 
USA

KBI Biopharma Inc

 
 
USA

Kedalion Therapeutics, Inc.

 
USA

Kelun Pharmaceuticals

 
 
Netherlands

Kiadis Pharma

 
 
United States

Kingdom Capital

 
 
United States

Kingdom Capital, LLC

 
Canada

KisoJi Biotechnology

 
Israel

Kitov Pharmaceuticals

 
 
USA

Kleo Pharmaceuticals

 
 
United States

Korea Venture Investment Corp.

 
USA

Kowa Research Institute Inc

 
 
USA

KromaTiD

 
USA

KromaTiD Inc

 
Japan

Kyowa Hakko Kirin Co Ltd

 
 
United States

L2 Capital, LLC

 
USA

LA BioMed

 
Australia

Lachesis Biosciences Ltd

 
 
China

Lake Capital

 
USA

Lakewood-Amedex

 
 
United States

Landmark Angels, Inc. /Landmark Family Office

 
 
United States

Landmark Angels/Family Office

 
 
United States

Landmark Angels/Landmark Family Office

 
 
USA

Landos Biopharma

 
USA

Larchmont Ventures

 
 
USA

Latham Biopharm Group

 
USA

LatticePoint Consulting

 
USA

LaVoie HealthScience

 
USA

LaVoieHealthScience

 
 
Korea, South

LB Investment

 
 
USA

Leading BioSciences Inc

 
USA

Leading BioSciences, Inc.

 
USA

Leerink Partners

 
South Korea

LegoChem Biosciences

 
USA

Lexicon Pharmaceuticals Inc

 
South Korea

LG Chem

 
Japan

LiberoThera Co., Ltd.

 
 
United States

Lif e Biosciences

 
USA

Life Chemicals

 
Canada

Life Chemicals Inc.

 
 
United States

Life Science Angels

 
 
USA

Life Science Leader

 
 
USA

Life Science Leader magazine

 
USA

Life Science Washington

 
 
United Kingdom

LifeArc

 
USA

LifeTech & Aegis Capital

 
 
USA

LifeTech Capital Aegis

 
 
China

Lilly Asia Ventures

 
 
United States

Lilly Asia Ventures (LAV)

 
 
United States

Lincoln Park Capital

 
 
Australia

Linear Clinical Research

 
China

Lingmed

 
 
Japan

LINK-J

 
 
United States

LLEX Partners

 
United Kingdom

Locate Bio Limited

 
USA

Locust Walk

 
Hong Kong

Longenesis

 
USA

Longevity Biotech, Inc

 
USA

Lonza

 
 
USA

Loop Capital Markets

 
 
USA

Loudoun County Economic Development

 
 
USA

Lowenstein Sandler LLP

 
USA

Lowenstein Sandler LLP/Aural Analyt

 
 
Australia

Luina Bio Pty Ltd

 
 
Canada

Lumira Capital

 
 
Canada

Lumira Ventures

 
China

Luoxin Biotechnology(Shanghai) Co.,

 
China

Luoxin Pharm

 
 
China

LYFE Capital

 
 
United States

Lymo Ventures - Life Science Angels

 
USA

Lynkogen Inc.

 
 
China

Lynx Capital Limited

 
 
Netherlands

M Ventures

 
Switzerland

Mabylon AG

 
 
USA

MacDougall Biomedical

 
 
USA

Machavert Pharmaceuticals

 
Japan

Macnica Inc

 
 
USA

Maculus Therapeutix

 
Sweden

Magle Chemoswed

 
Sweden

Magle Chemoswed AB

 
USA

MaidStone Life Sciences

 
 
Russian Federation

Management company RUSNANO LLC

 
 
United States

Maple Leaf Partners, LP

 
 
Canada

MaRS

 
Japan

Maruho Co Ltd

 
USA

MassBio

 
USA

Mateon Therapeutics

 
 
USA

Matinas BioPharma

 
 
USA

MatriSys Bioscience

 
 
United States

Matrix Partners China

 
 
USA

MaxCyte

 
USA

Maxim Investment Banking

 
 
USA

Maxim Merchant Capital

 
France

Mayoly Spindler

 
 
Japan

MBL Venture Capital Co., Ltd.

 
 
USA

McDonnell Boehnen Hulbert & Berghoff LLP

 
USA

MD ACCESS, LLC

 
USA

MD Anderson

 
USA

MDNA Life Sciences

 
USA

Medac Pharma

 
 
USA

MedCity News

 
 
USA

Medical Marketing Economics LLC

 
Canada

Medicenna Therapeutics Inc

 
USA

Medimmune

 
 
United States

Mediqventures

 
 
Korea, South

Medivate Partners

 
 
Korea, South

Medivate Partners, Inc.

 
Canada

Med-Life Discoveries

 
 
USA

Medmarc

 
 
United States

MedPro Investors

 
 
United States

MedPro Investors LLC

 
 
USA

Medtech Insight

 
USA

Meg Malloy

 
USA

Melior Pharmaceuticals

 
 
United States

Melissa Krauth (individual investor)

 
Switzerland

Memo-Therapeutics AG

 
USA

Mentrik Biotech

 
 
Netherlands

MercachemSyncom

 
USA

MERCK

 
USA

Merck KGaA, Darmstadt, Germany

 
 
United States

Mercury Fund

 
 
United Kingdom

Mereo BioPharma

 
 
USA

Mergermarket

 
 
USA

MergerMarket Acuris Group

 
 
United States

Mesa Verde Venture Partners

 
 
USA

Mesoblast

 
Japan

Metcela Inc.

 
 
United States

Meyers Investments Family Lp

 
 
United States

MGD Ventures LLC

 
USA

MichBio

 
USA

Microbiotix Inc

 
 
United States

Mid Atlantic Bio Angels

 
 
United States

Mighty Capital

 
 
United States

Militia Hill Ventures

 
USA

Millendo Therapeutics

 
 
Russian Federation

Millhouse

 
 
USA

Milliman

 
 
USA

Millipore Sigma

 
 
Germany

Miltenyi Biotec

 
 
United Kingdom

MiNA Therapeutics

 
 
United Kingdom

MIP Diagnostics Ltd

 
 
United States

Mission Bay Capital

 
 
United States

MIT Alumni Angels of Northern California

 
 
United States

Mitsui Global Investment

 
 
United States

Mizuho Bank

 
 
USA

Mobillion Systems Inc

 
Japan

Mochida Pharmaceutical Co., Ltd.

 
 
United Kingdom

Momentum Biotech

 
Japan

Momotaro-Gene Inc

 
Canada

Monogenic Pharmaceuticals

 
 
United States

Moore Venture Partners

 
 
China

Morningside Ventures

 
 
USA

Motus GI, Inc.

 
 
United States

MP Healthcare Venture Management

 
 
United States

MPM Capital

 
 
Switzerland

MTIP

 
USA

Multitude Therapeutics

 
China

Multitude/Abmart

 
Japan

Mundipharma KK

 
 
United States

MVP Capital Partners

 
USA

MyBioGate Inc

 
 
United States

Mybiogate inc.

 
USA

Nabriva Therapeutics

 
 
China

Nanjing Leads Biolabs Co., Ltd.

 
China

Nanjing Sanhome Pharmaceutical

 
 
United States

NanoDimension

 
 
USA

NANOGAP Therapeutics

 
USA

NANOLOGY LLC

 
USA

NanoValent Pharmaceuticals Inc

 
 
USA

NanoValent Pharmaceuticals, Inc.

 
 
USA

Nanoviricides

 
 
USA

Nashville Biosciences

 
 
USA

Nature Biotechnology

 
 
USA

Navan Technologies, Inc.

 
 
USA

Navigen, Inc.

 
 
USA

NDA Group

 
 
Sweden

NDA Group AB

 
United Kingdom

Neem Biotech Ltd

 
 
United Arab Emirates

NEGMA GROUP

 
USA

Neolight, LLC

 
 
Iceland

Nepsone ehf

 
 
United Kingdom

NeRRe Therapeutics

 
 
Australia

Neuclone

 
USA

Neurocrine Biosciences

 
Canada

Neurolign Technologies Inc.

 
 
USA

NeuroMetrix, Inc.

 
 
Australia

Neuroscience Trials Australia

 
 
USA

Neurotech Reports

 
USA

New Enterprise Associates

 
USA

New Horizons Pharma

 
USA

New Perspectives Inc

 
 
United States

New Rhein Healthcare Investors

 
 
United States

New Science Ventures

 
 
United States

New York City Economic Development Corporation

 
USA

New5win

 
Spain

NewCo - Rafael Leon

 
 
USA

NewsmexxTV

 
 
Japan

Newton Biocapital SA

 
 
South Korea

NIBEC

 
Japan

Nissan Chemical Corporation

 
 
USA

Nitrome Biosciences

 
 
Belgium

NLO BVBA

 
Japan

Nobelpharma Co., Ltd.

 
 
United States

Noble Life Science Partners

 
 
Canada

NoNO Inc.

 
Germany

Nordmark Arzneimittel GmbH & Co KG

 
 
United States

Northlea Partners LLLP

 
 
Germany

Novaliq GmbH

 
 
Switzerland

Novaremed AG

 
 
USA

Novian Health Inc.

 
 
Denmark

Novo Holdings A/S

 
USA

Novo Nordisk

 
Denmark

Novo Nordisk A S

 
 
Australia

Novotech

 
 
USA

Novotech CRO

 
 
Germany

NRW.BANK / Gründerfonds Ruhr

 
 
United States

NSIP LLC

 
Australia

Nucleus Network

 
USA

Numerate Inc

 
 
United Kingdom

O2h Ventures Ltd

 
 
United States

Oceaniq Capital Partners

 
 
Hong Kong

oceanpine capital

 
 
USA

OCT Group LLC

 
Belgium

Octimet Oncology NV

 
Canada

ODS Medical

 
 
USA

OHM ONCOLOGY, INC.

 
Japan

Okinawa Protein Tomography Ltd

 
USA

Olix Pharmaceuticals

 
USA

Ology Bioservices